1. Sipuleucel-T (Provenge^®)—Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention

   • Szymon Jarosławski
   • Mondher Toumi

   Current Opinion 24 September 2015 Pages: 301 - 307

2. Pharmacovigilance Considerations for Biosimilars in the USA

   • Gustavo Grampp
   • Thomas Felix

   Current Opinion Open access 29 September 2015 Pages: 309 - 321

   

3. FDA Draft Guidance on the Naming of Biosimilars

   • Sara Fernandez-Lopez

   Commentary 19 October 2015 Pages: 323 - 325

4. Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast

   • Melinda Gooderham
   • Kim Papp

   Review Article Open access 19 October 2015 Pages: 327 - 339

   

5. Ramucirumab: A Review in Advanced Gastric Cancer

   • Sarah L. Greig
   • Gillian M. Keating

   Adis Drug Evaluation 04 September 2015 Pages: 341 - 351

   

6. Bivalent rLP2086 Vaccine (Trumenba^®): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10–25 Years

   • Matt Shirley
   • Sohita Dhillon

   Adis Drug Evaluation 22 September 2015 Pages: 353 - 361